RE-SAMPLE
@resample_h2020
Followers
104
Following
160
Media
80
Statuses
201
#H2020 project, real-world data #RWD monitoring and #AI, improved understanding of #COPD and comorbidity for personalised, proactive care. Project owners' views
Joined February 2021
The paper from colleagues at @RRDNL is accepted as case study for #NordiCHI2024 under @resample_h2020 . They investigated the attitudes of people with #copd towards health monitoring, risk predictions and #virtualcoaching. We hope to see you in Uppsala at their presentation!
0
0
1
Our new @resample_h2020 #newsletter is out! 🥳. Want to know more about our last activities? Interested about the #gdpr or continuous #enduser involvement? You can read about this and a lot more in our last edition!.➡️ #research #horizon2020 #copd #ehealth
0
0
1
In @resample_h2020, we're validating #machinelearning models using data from 3 hospitals to power our Virtual Companionship Programme.Our approach: re-sampling, cross-validation, permutation testing & interpretability for transparency. Ensuring fairness, accuracy & reliable care!
0
1
4
Yesterday, @ProjectWarifa & @resample_h2020 met to discuss #synergies & collaboration!.WARIFA works to develop a prototype of a combined early #riskassessment tool that will provide individual citizens with #personalized #recommendations for the management of #chronicconditions.
Today, @ProjectWarifa and @resample_h2020 joined forces to explore synergies and foster #awareness. RE-SAMPLE is working to transform the #healthcare journey of #COPD patients, and to set a standard of care for patients suffering from complex chronic conditions. Stay tuned!
0
0
1
2nd day of #work for our consortium meeting! .Discussions and cooperation are intense and insightful on the @resample_h2020 solution! .A lot of thanks to @DFKI for hosting us! .#resarch #cooperation #horizon2020 #copd
0
1
4
Let’s go! .Today, @resample_h2020 partners are meeting in Bremen thanks to @DFKI for 3 days of work!
0
0
3
Last week a new article was published under @resample_h2020 titled “Technology-supported shared decision-making in chronic conditions: A systematic review of randomized controlled trials”! . Want to read more about it? Check out the open access paper:
0
0
2
RT @EuroRespSoc: 💡 The 22nd ERS Lung Science Conference is officially underway!. ERS Conference & Seminars Director Prof. Silke Meiners off….
0
6
0
@resample_h2020 supports patient-centeredness & encourage individuals to take an active role in their health through Shared Decision Making (SDM).Healthentia clinical platform enables clinicians & patients to set achievable goals, track progress & conduct follow-up appointments
0
0
0
RT @fritsfranssen: Potential mechanisms driving the increased risk of cardiovascular comorbidities in patients with COPD .
0
23
0
RT @EuroRespSoc: The ERS Lung Science Conference 2024 gets underway from tomorrow in Estoril, Portugal!. 📱 Join the conversation on social….
0
9
0
RT @ERSpublications: ERJOR: Real-world walking cadence should be further considered as a prognostic marker of COPD in observational researc….
0
9
0
RT @ERSpublications: ERJ Open Research: In smokers aged 40–49 years, centrilobular emphysema and the airway/lung size ratio on CT were inde….
0
20
0
RT @EuroRespSoc: 📖 Order the ERS Monograph on COPD in the 21st Century now!. This new Monograph provides an up-to-date overview of what is….
0
3
0
RT @EuroRespSoc: One week to go until the ERS Lung Science Conference 2024 gets underway. There is still time to register for this year’s….
0
6
0
@resample_h2020 platform employs @HL7 standard & @SnomedCT terminology to enhance the utilisation of #healthdata in #MachineLearning . This commitment to #Interoperability is a cornerstone of RE-SAMPLE, unlocking new dimensions in #data analysis for improved #patient outcomes
0
3
3
@resample_h2020 released the 9th edition of its #newsletter! Read it here ➡ We present you another member of our #consortium, some news & the amazing work of our partners on #publications with 4 new #articles since our last newsletter! .#ehealth #rwd.
Today @resample_h2020 released the 9th edition of its #newsletter!.Read it here ➡ We present you another member of our #consortium, some news & the amazing work of our partners on #publications with 4 new #articles since our last newsletter!. #ehealth
0
1
1
RT @ERSpublications: The ERS Tobacco Control Committee finds lack of evidence supporting the tobacco industry's “harm reduction” claims. Al….
0
10
0
Today @resample_h2020 released the 9th edition of its #newsletter!.Read it here ➡ We present you another member of our #consortium, some news & the amazing work of our partners on #publications with 4 new #articles since our last newsletter!. #ehealth
0
0
0